Workflow guide · Monitoring basics

How to Build Your First Biotech Watchlist

Start small, define why each company is included, and connect every watchlist item to a future decision.

New Biotech InvestorsUpdated 2026-07-26Practical workflow

The situation

When this workflow becomes useful

A new investor wants to follow biotech but quickly accumulates dozens of tickers from social media, catalyst lists, and conference coverage.

Best fit

Investors new to biotechnology, drug development, clinical trials, FDA events, or catalyst-driven stock research.

The challenge

Why the obvious approach breaks down

A large watchlist creates noise without improving understanding. The investor needs a small set of names tied to clear research questions.

How to think about the task

The reasoning behind the workflow

A watchlist is useful when every entry represents an active question. Adding tickers without a reason creates a feed that grows faster than understanding and makes genuinely important alerts harder to recognize.

A beginner should start with a small number of companies and record why each one deserves attention, which event comes next, and what would cause the company to be removed.

Give every company a monitoring thesis

The reason can be a lead program, upcoming readout, FDA date, target relationship, or financing question. A sentence is enough, but it should be specific enough to determine which news matters.

Use priorities instead of one flat list

Holdings, active research, catalyst monitoring, and background peers deserve different alert settings. Immediate delivery should be reserved for events that can change an active decision.

Design an exit rule for the watchlist

After a catalyst passes or the research question is resolved, remove, downgrade, or redefine the entry. A watchlist that never shrinks eventually stops reflecting actual attention.

Illustrative example

Illustrative five-company starting list

A new investor selects two companies for active research, one holding, and two target peers. Each receives a lead asset, next event, reason for watching, priority, and review date.

When one catalyst passes, the company remains only if a new question is written. The list stays small enough that every alert can be interpreted in context.

Questions to answer before making a decision

  • Why is this company on the list?
  • What next event or question am I monitoring?
  • How urgently should matching news be delivered?
  • When will I remove or reclassify the company?

The workflow

A repeatable way to do the work

  1. 01

    Begin with a handful of companies you can explain in one sentence each.

  2. 02

    Record the lead program, stage, next catalyst, and reason for watching.

  3. 03

    Add only the closest competitors or target-level keywords.

  4. 04

    Use different priorities for holdings, active research, and background monitoring.

  5. 05

    Remove or downgrade names after the relevant catalyst or research question is resolved.

Monitoring checklist

Signals to keep visible

Ticker and company news
Lead-program updates
Catalyst-date changes
Competitor read-through
Financing and runway news

Common mistakes

  • Adding a ticker without a research question
  • Giving every company the same alert priority
  • Never cleaning the list after catalysts pass

Output and outcome

What good looks like

Deliverable

A focused watchlist with a reason, next event, alert priority, and review date for every company.

Practical outcome

The investor receives less irrelevant news and can connect each update to a specific question or planned research action.

Where BioPharmSignal fits

Reduce the collection work around the decision.

Use LiveFeed and company pages for source-linked monitoring, the PDUFA Calendar for upcoming FDA milestones, and watchlists or alerts to keep the relevant tickers and keywords visible. The workflow still requires independent research and judgment.

Frequently asked questions

Who is this workflow for?

It is designed for new biotech investors and adjacent biotech research users who need a repeatable, source-linked way to complete this task.

What should this workflow produce?

A focused watchlist with a reason, next event, alert priority, and review date for every company.

What is the practical benefit?

The investor receives less irrelevant news and can connect each update to a specific question or planned research action.